Moreover, treatment with recombinant human IL-33 abrogated the TTP-mediated inhibition of tumor growth and metastasis, suggesting that the tumor-suppressive role of TTP in GC is associated with IL-33 suppression. This evidence concerns the gene IL33 and neoplasm.